Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Lipson, EJ; Lilo, MT; Ogurtsova, A; Esandrio, J; Xu, HY; Brothers, P; Schollenberger, M; Sharfman, WH; Taube, JM

Lipson, EJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.; Lipson, EJ (reprint author), Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA.; Lipson, EJ (reprint author), John

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017; 5 ( ):

Abstract

Monoclonal antibodies that block immune regulatory proteins such as programmed death-1 (PD-1) have demonstrated remarkable efficacy in controlling the......

Full Text Link